Neurotrope Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 7
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 6
  • Investments
  • 2

Neurotrope General Information

Description

Neurotrope Inc is a biopharmaceutical company. The company is principally focused on developing a product platform based on a drug candidate called bryostatin for the treatment of Alzheimer's disease ("AD"), which is in the clinical testing stage. It is also developing bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C, which are in pre-clinical testing.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Therapeutic Devices
Primary Office
  • 1185 Avenue of the Americas
  • 3rd Floor
  • New York, NY 10036
  • United States
+1 (973) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurotrope Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurotrope‘s full profile, request access.

Request a free trial

Neurotrope Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurotrope Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neurotrope‘s full profile, request access.

Request a free trial

Neurotrope Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 02-Dec-2020 0000000 000000 Drug Discovery
Blueflash Communications 29-Aug-2013 Merger/Acquisition Application Software
To view Neurotrope’s complete acquisitions history, request access »